Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval.<br />Moderna will submit its <br />coronavirus vaccine on Nov. 30.<br />It is the second drugmaker to ask the FDA <br />for emergency use authorization.<br />Pfizer and BioNTech submitted <br />their vaccine on Nov. 20.<br />AstraZeneca, a third drugmaker with a promising vaccine, is planning to run additional tests after finding a technical error during its trial.<br />In a statement, Moderna said that its vaccine is 100% effective — across all ages, genders and races — at preventing severe cases of coronavirus.<br />The company anticipates that <br />the FDA's Vaccines and Related <br />Biological Products Advisory Committee <br />will discuss the submission on Dec. 17.<br />Each of these vaccines utilize mRNA, which "tricks" the body into developing an immune response.<br />According to NBC News, an mRNA-based <br />drug has never won approval before.
